Measuring fatigue in Parkinson's disease:: A psychometric study of two brief generic fatigue questionnaires

被引:85
作者
Hagell, Peter
Hoglund, Arja
Reimer, Jan
Eriksson, Brita
Knutsson, Ingmari
Widner, Hakan
Cella, David
机构
[1] Lund Univ, Dept Hlth Sci, SE-22100 Lund, Sweden
[2] Lund Univ, Vardal Inst, SE-22100 Lund, Sweden
[3] Lund Univ, Swedish Inst Hlth Sci, SE-22100 Lund, Sweden
[4] Univ Lund Hosp, Dept Neurol, S-22185 Lund, Sweden
[5] Karolinska Univ, Huddinge Hosp, Dept Neurol, Stockholm, Sweden
[6] Sahlgrens Univ Hosp, Dept Neurol Rehabil, S-41345 Gothenburg, Sweden
[7] Sahlgrens Univ Hosp, Arvid Carlsson Inst Neurosci, S-41345 Gothenburg, Sweden
[8] Linkoping Univ, Fac Hlth Sci, Dept Neurol, Div Neurosci & Locomot, Linkoping, Sweden
[9] Northwestern Univ, Evanston, IL USA
[10] Evanston NW Healthcare, Ctr Outcomes Res & Educ, Evanston, IL USA
关键词
fatigue; Parkinson's disease; questionnaires; reliability; validity;
D O I
10.1016/j.jpainsymman.2006.05.021
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
This study evaluated and compared the measurement properties of the 13-item Functional Assessment of Chronic Illness Therapy-Fatigue Scale (FACIT-F) and the 9-item Fatigue Severity Scale (FSS) in 118 consecutive Parkinson's disease (PD) patients, using traditional and Rasch measurement methodologies. Both questionnaires exhibited excellent data quality and reliability (coefficient alpha >= 0.9), and acceptable rating scale functionality, and both discriminated between fatigued and nonfatigued patients. factor and Rasch analyses provided general support for unidimensionality of both FACIT-F and FSS, although they do not appear to measure identical aspects of fatigue. No signs of differential item functioning (DIF) were found for the FACIT-F, whereas potential age DIF, was detected for two FSS items. These results support the measurement validity of both questionnaires in PD, although the FACIT-F displayed better measurement precision and modest psychometric advantages over the FSS. Availability of psychometrically sound fatigue measures that are applicable across disorders provides a sound basis for advancing the understanding of this common and distressing complaint.
引用
收藏
页码:420 / 432
页数:13
相关论文
共 60 条
[1]  
Aaronson N, 2002, QUAL LIFE RES, V11, P193
[2]   Fatigue in patients with Parkinson's disease [J].
Abe, K ;
Takanashi, M ;
Yanagihara, T .
BEHAVIOURAL NEUROLOGY, 2000, 12 (03) :103-106
[3]   Is fatigue an independent and persistent symptom in patients with Parkinson disease? [J].
Alves, G ;
Wentzel-Larsen, T ;
Larssen, JP .
NEUROLOGY, 2004, 63 (10) :1908-1911
[4]   Multilingual translation of the functional assessment of cancer therapy (FACT) quality of life measurement system [J].
Bonomi, AE ;
Cella, DF ;
Hahn, EA ;
Bjordal, K ;
SpernerUnterweger, B ;
Gangeri, L ;
Bergman, B ;
WillemsGroot, J ;
Hanquet, P ;
Zittoun, R .
QUALITY OF LIFE RESEARCH, 1996, 5 (03) :309-320
[5]   The Parkinson fatigue scale [J].
Brown, RG ;
Dittner, A ;
Findley, L ;
Wessely, SC .
PARKINSONISM & RELATED DISORDERS, 2005, 11 (01) :49-55
[6]  
Cella D, 2005, J RHEUMATOL, V32, P811
[7]   Epoetin alfa treatment results in clinically significant improvements in quality of life in anemic cancer patients when referenced to the general population [J].
Cella, D ;
Zagari, MJ ;
Vandoros, C ;
Gagnon, DD ;
Hurtz, HJ ;
Nortier, JWR .
JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (02) :366-373
[8]   Combining anchor and distribution-based methods to derive minimal clinically important differences on the functional assessment of cancer therapy (FACT) anemia and fatigue scales [J].
Cella, D ;
Eton, DT ;
Lai, JS ;
Peterman, AH ;
Merkel, DE .
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2002, 24 (06) :547-561
[9]   Fatigue in cancer patients compared with fatigue in the general United States population [J].
Cella, D ;
Lai, JS ;
Chang, CH ;
Peterman, A ;
Slavin, M .
CANCER, 2002, 94 (02) :528-538
[10]   Fatigue and basal ganglia [J].
Chaudhuri, A ;
Behan, PO .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 2000, 179 (1-2) :34-42